The Breath project (Project Number: 2022-1-PL01-KA220-HED-000089283) has been Co-funded by the European Union. Views and opinions expressed are however those of the author or authors only and do not necessarily reflect those of the European Union or the Foundation for the Development of the Education System. Neither the European Union nor the entity providing the grant can be held responsible for them.

Lithuania has a comparatively comprehensive asthma strategy, with severe asthma guidelines and tobacoo control laws

Sanofi and Regeneron Pharmaceuticals

Thematic Area
Epidemiology, Organization of national health service, Management, Rehabilitation paths, Rehabilitation structures, Patients’ perspective
Summary
Lithuania is among the highest scoring in terms of Policy Context. This is attributable to having a comparatively comprehensive asthma strategy, having severe asthma guidelines, and having an above-average score in tobacco control laws. Lithuania could improve its Policy Context score by reporting data to a severe asthma registry and addressing the limited alignment of its national care guidelines with international best practices. In terms of Access and Care Coverage, Lithuania is among the lowest scoring, based primarily on low levels of access to treatment (including biologics) and digital therapeutics. Despite these measures, Lithuania scores highly in terms of Disease Burden score, with among the lowest estimated societal cost of severe asthma and percentage of DALYs attributable to asthma, as well as the lowest percentage of deaths attributable to asthma. Having among the highest adult obesity and tobacco use rates prevents Lithuania from scoring higher in this category.
Relevance
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Lithuania